Charleston Breast Center

Recent papers from Charleston Breast Center

1. Adverse events seen with fillersDermatological Reviews · 2023
2. Future of dermal fillersDermatological Reviews · 2023
3. Restylane: What we knowDermatological Reviews · 2023
4. Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancerSurgical Oncology · 2022
5. Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene SignatureJCO Precision Oncology · 2022
6. COVID-19 Pandemic and Beyond: Considerations and Costs of Telehealth Exercise Programs for Older Adults With Functional Impairments Living at Home—Lessons Learned From a Pilot Case StudyPhysical Therapy · 2020
7. Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancersnpj Breast Cancer · 2019
8. Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular SubtypingAnnals of Surgical Oncology · 2016
9. Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)Annals of Surgical Oncology · 2014
10. Racial disparities in breast cancer mortality in a multiethnic cohort in the SoutheastCancer · 2011
11. Racial differences in follow‐up of abnormal mammography findings among economically disadvantaged womenCancer · 2009
12. Localized Palmar–Plantar Epidermal Hyperplasia: A Previously Undefined Dermatologic Toxicity to SorafenibThe Oncologist · 2007
13. Tourist Attraction Devevlopment Modeling: Public Sector Policy and Management CaseReview of Regional Studies · 1982